XML 39 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Operating expenses      
Research and development $ 11,327 $ 18,381 $ 16,977
General and administrative 3,412 7,078 11,556
Total operating expenses 14,739 25,459 28,533
Financing income, net (794) (1,238) (353)
Loss before taxes 13,945 24,221 28,180
Tax benefit 0 0 (534)
Net loss for the year $ 13,945 $ 24,221 $ 27,646
Basic loss per Ordinary Share $ 0.039 $ 0.103 $ 0.121
Diluted loss per Ordinary Share $ 0.039 $ 0.103 $ 0.121
Weighted average number of Ordinary Shares outstanding, basic [1] 359,048,638 234,998,859 227,589,288
Weighted average number of Ordinary Shares outstanding, diluted [2] 359,048,638 234,998,859 227,589,288
[1] Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1)
[2] 1 American Depositary Share (ADS) represents 20 Ordinary Shares.